Document is current
Any future updates will be listed below
-
Authors
Golden, Emily
Rashwan, Rabab
Woodward, Eleanor A.
Sgro, Agustin
Wang, Edina
Sorolla, Anabel https://orcid.org/0000-0001-8238-8763
Waryah, Charlene
Tie, Wan Jun
Cuyàs, Elisabet
Ratajska, Magdalena https://orcid.org/0000-0001-7015-1865
Kardaś, Iwona
Kozlowski, Piotr https://orcid.org/0000-0003-3770-7715
Johnstone, Elizabeth K. M. https://orcid.org/0000-0001-7990-371X
See, Heng B.
Duffy, Ciara
Parry, Jeremy
Lagerborg, Kim A. https://orcid.org/0000-0002-9101-0022
Czapiewski, Piotr
Menendez, Javier A.
Gorczyński, Adam
Wasag, Bartosz https://orcid.org/0000-0002-3634-7562
Pfleger, Kevin D. G.
Curtis, Christina https://orcid.org/0000-0003-0166-3802
Lee, Bum-Kyu
Kim, Jonghwan https://orcid.org/0000-0002-9919-9843
Cursons, Joseph https://orcid.org/0000-0002-5053-4540
Pavlos, Nathan J.
Biernat, Wojciech https://orcid.org/0000-0001-8462-2189
Jain, Mohit
Woo, Andrew J. https://orcid.org/0000-0003-1198-6373
Redfern, Andrew
Blancafort, Pilar https://orcid.org/0000-0002-3881-7396
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1130212)
Department of Health | National Health and Medical Research Council (APP1069308)
Department of Health | National Health and Medical Research Council (APP1147528)
- License Information
-
More Information
Article History
Received: 31 October 2020
Accepted: 25 February 2021
First Online: 26 March 2021
Competing interests
: A.R. acts in an advisory capacity to Pfizer (who make an mTOR inhibitor and a CDK 4/6 inhibitor), Novartis (who make a CDK 4/6 inhibitor) as well as AstraZeneca and Roche. J.C. is an employee of oNKo-Innate Pty Ltd. K.P. received funding from Promega, BMG Labtech, and Dimerix as ARC Linkage Grant participating organizations. These participating organizations played no role in any aspect of the conception or design of the research, collection, analysis, and interpretation of the results, or writing and editing of the paper. K.P. is the chief scientific advisor of Dimerix, of which he maintains a shareholding. All other authors declare no competing interests.
